Emparol-L Tablet 10 mg+5 mg is a combination oral anti-diabetic medication containing Empagliflozin (10 mg) and Linagliptin (5 mg). This formulation is specifically designed for the management of type 2 diabetes mellitus (T2DM) in adults, providing enhanced blood sugar control through dual mechanisms of action.

• Empagliflozin, a SGLT2 (sodium-glucose co-transporter 2) inhibitor, works by reducing glucose reabsorption in the kidneys, promoting urinary glucose excretion, lowering blood sugar levels, and supporting weight management. It also provides cardiovascular protection in patients with established heart disease.

• Linagliptin, a DPP-4 (dipeptidyl peptidase-4) inhibitor, enhances incretin hormone activity, which stimulates insulin secretion and decreases glucagon release in response to meals. This helps control both fasting and postprandial blood glucose.

By combining these two agents, Emparol-L 10 mg+5 mg provides comprehensive glycemic control, targeting both renal glucose excretion and pancreatic insulin regulation. This combination is particularly useful for patients whose blood sugar levels are not adequately controlled by diet, exercise, or monotherapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Emparol-L Tablet 10 mg+5 mg is indicated for:

• Type 2 Diabetes Mellitus (T2DM): To improve glycemic control in adults inadequately controlled on diet, exercise, or single anti-diabetic therapy

• Adjunct therapy: Can be combined with other anti-diabetic medications, including metformin, under medical supervision

• Fasting and postprandial glucose control: Helps maintain stable blood sugar levels throughout the day

• Cardiovascular risk reduction: Empagliflozin component may reduce the risk of heart failure hospitalization and cardiovascular death in adults with T2DM and existing heart disease

• Weight management: Supports modest weight reduction through urinary glucose excretion

Dosage and Administration

• Adults: One tablet once daily, preferably in the morning, with or without food, or as directed by a healthcare provider

• Swallow the tablet whole with water; do not crush, chew, or split

• Blood glucose, HbA1c, and renal function should be monitored regularly

• Maintain dietary control and regular exercise alongside the medication for optimal results

• Dose adjustment may be necessary for patients with renal impairment or other medical conditions

Precautions

• Not recommended for patients with type 1 diabetes, severe renal impairment, or end-stage renal disease

• Use caution in patients with a history of urinary tract infections, genital infections, or dehydration

• Avoid use in patients with severe liver disease unless prescribed by a physician

• Monitor for hypoglycemia when used with insulin or sulfonylureas

• Inform your healthcare provider of all medications being taken to avoid drug interactions

• Pregnant and breastfeeding women should consult a physician before using this medication

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Emparol-L Tablet 10 mg+5 mg is generally well tolerated. Common side effects may include:

• Increased urination

• Urinary tract infections

• Genital yeast infections

• Nasopharyngitis

• Mild headache or dizziness

Rare but serious side effects may include:

• Ketoacidosis (high blood ketones)

• Severe dehydration or low blood pressure

• Hypoglycemia when combined with insulin or sulfonylureas

• Kidney impairment or electrolyte imbalance

• Severe allergic reactions, including rash, swelling, or difficulty breathing

Patients experiencing serious or persistent side effects should seek immediate medical attention.

Storage

Store in a cool, dry place below 30°C, protected from sunlight and moisture. Keep out of reach of children.

Emparol-L Tablet 10 mg+5 mg provides dual-action glycemic control through the combined benefits of Empagliflozin and Linagliptin, helping adults achieve better blood sugar management, cardiovascular protection, and modest weight reduction. Its once-daily dosing makes it a convenient and reliable option for type 2 diabetes management.